Test ID MCRPL Macroprolactin, Serum
Specimen Required
Patient Preparation: For 12 hours before specimen collection do not take multivitamins or dietary supplements containing biotin (vitamin B7), which is commonly found in hair, skin, and nail supplements and multivitamins.
Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Forms
If not ordering electronically, complete, print, and send an Oncology Test Request (T729) with the specimen.
Secondary ID
34643Useful For
Determining biologically active levels of prolactin, in asymptomatic patients with elevated prolactin levels
Ruling out the presence of macroprolactin
Profile Information
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
TOPRL | Prolactin,Total,S | Yes, (order PRL) | Yes |
PEGPR | Prolactin,Unprecipitated,S | No | Yes |
Method Name
TOPRL: Electrochemiluminescent Immunoassay
PEGPR: Polyethylene Glycol (PEG) Precipitation Followed by Electrochemiluminescent Immunoassay
Reporting Name
Macroprolactin, SSpecimen Type
SerumSpecimen Minimum Volume
0.6 mL
Specimen Stability Information
Specimen Type | Temperature | Time | |
---|---|---|---|
Serum | Refrigerated (preferred) | 7 days | |
Frozen | 90 days | ||
Ambient | 24 hours |
Clinical Information
Prolactin is secreted by the anterior pituitary gland under negative control by dopamine, which is secreted by the hypothalamus. The only physiological function of prolactin is the stimulation of milk production. In normal individuals, the prolactin concentration in blood rises in response to physiologic stimuli such as nipple stimulation, sleep, exercise, sexual intercourse, and hypoglycemia. Certain medications, (eg, phenothiazines, metoclopramide, risperidone, selective serotonin reuptake inhibitors, estrogens, verapamil) may also cause hyperprolactinemia. Pathologic causes of hyperprolactinemia include prolactin-secreting pituitary adenoma (prolactinoma), diseases of the hypothalamus, primary hypothyroidism, section compression of the pituitary stalk, chest wall lesions, renal failure, and ectopic tumors.
Hyperprolactinemia may also be caused by the presence of a high-molecular-mass complex of prolactin called macroprolactin (typically due to prolactin bound to immunoglobulin). In this situation, the patient is asymptomatic. Hyperprolactinemia attributable to macroprolactin is a frequent cause of misdiagnosis and mismanagement of patients. Macroprolactin should be considered if, in the presence of elevated prolactin levels, signs and symptoms of hyperprolactinemia are absent, or pituitary imaging studies are not informative.
Reference Values
PROLACTIN, TOTAL
Males
<18 years: not established
≥18 years: 4.0-15.2 ng/mL
Females
<18 years: not established
≥18 years: 4.8-23.3 ng/mL
PROLACTIN, UNPRECIPITATED
Males
<18 years: not established
≥18 years: 2.7-13.1 ng/mL
Females
<18 years: not established
≥18 years: 3.4-18.5 ng/mL
When the percent of the precipitated (complexed) prolactin fraction of the total prolactin is 60% or less, the result is considered negative for macroprolactin.
Cautions
Demonstration of the presence of macroprolactin does not exclude the possibility of concomitant presence of pituitary adenoma. Results should be interpreted in conjunction with clinical findings.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 3 daysPerforming Laboratory

Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
84146 x 2